Security key
04280A100
ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (ARWR)
CUSIP: 04280A100
Q3 2016 13F Holders as of 30 Sep 2016
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 30,122,030
- Total 13F value
- $221,392,091
- Share change
- +9,533,083
- Put/Call ratio
- 208%
- SEC-reported price per share
- $7.35
- Number of holders
- 94
- Value change
- +$70,394,875
- Number of buys
- 54
- Number of sells
- 26
- Shares outstanding
- 141,328,976
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2016
Institutions
94
Top holders
10
ARWR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2016
Previous quarter: Q2 2016
ARROWHEAD PHARMACEUTICALS, INC. SEC filings
ARROWHEAD PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04280A100
Recent filing periods:
Ownership snapshot
Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
OppenheimerFunds, Inc.
Disclosed value leader
OppenheimerFunds, Inc.
Comparable rows
15/15
Latest evidence
30 Jun 2016
13F
Lead comparable stake: 2.1%
Showing 1-6 of 15 holder rows.
Quick read
OppenheimerFunds, Inc. leads the comparable SEC ownership view at 2.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens OppenheimerFunds, Inc.'s linked filing trail.
Comparable ownership
Top 5
OppenheimerFunds, Inc.
2.1%
VANGUARD GROUP INC
1.7%
BlackRock Fund Advisors
1.7%
QVT Financial LP
1.4%
BlackRock Institutional Trust Com...
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
Company
|
2.1%
|
$15,960,000
3,000,000 shares
|
— | 30 Jun 2016 |
| VANGUARD GROUP INC |
13F
Company
|
1.7%
|
$13,015,000
2,446,346 shares
|
— | 30 Jun 2016 |
| BlackRock Fund Advisors |
13F
Company
|
1.7%
|
$12,447,000
2,339,588 shares
|
— | 30 Jun 2016 |
| QVT Financial LP |
13F
Company
|
1.4%
|
$10,894,000
2,047,782 shares
|
— | 30 Jun 2016 |
| BlackRock Institutional Trust Company, N.A. |
13F
Company
|
1.1%
|
$8,214,000
1,544,056 shares
|
— | 30 Jun 2016 |
| JPMORGAN CHASE & CO |
13F
Company
|
1%
|
$7,869,000
1,479,350 shares
|
— | 30 Jun 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2016
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
94
Shares
30,122,030
Rows available
94
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
84
Q3 2016 holders
94
Holder diff
10
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 value | Q3 2016 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend